The Centers for Medicare & Medicaid Services (CMS) is responsible for implementing laws passed by Congress related to Medicaid, the Children’s Health Insurance Program (CHIP), and the Basic Health Program. To implement these programs, CMS issues various forms of guidance to explain how laws will be implemented and what states and others need to do to comply. In addition to regulations, CMS issues sub-regulatory guidance to address policy issues as well as operational updates and technical clarifications of existing guidance.
Federal Policy Guidance
REFINE YOUR SEARCH:
Delay of Effective Date for Provision Relating to Manufacturer Reporting of Multiple Best Prices Connected to a Value Based Purchasing Arrangement; Delay of Inclusion of Territories in Definition of States and United States (CMS 2482-F2) Final Rule
Date:
Topics:
- Prescription Drugs
- Eligibility
Type: Regulations
Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements: Delay of Effective Date for Provision Relating to Manufacturer Reporting of Multiple Best Prices Connected to a Value Based Purchasing Arrangement; Delay of Inclusion of Territories in Definition of States and United States (CMS-2482-P2)
Date:
Topics:
- Prescription Drugs
- Eligibility
Type: Regulations
Mandatory Medicaid State Plan Coverage of Medication-Assisted Treatment
Date:
Topics:
- Benefits
- Prescription Drugs
- COVID-19
Type: State Health Official Letter
Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements (CMS 2482-F) Final Rule
Date:
Topics:
- Prescription Drugs
- Eligibility
Type: Regulations
Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements (CMS 2482-P)
Date:
Topics:
- Prescription Drugs
- Eligibility
Type: Regulations
Best Practices for Avoiding 340B Duplicate Discounts in Medicaid
Date:
Topics:
- Prescription Drugs
Type: Informational Bulletin
Covered Outpatient Drug; Further Delay Of Inclusion Of Territories In Definitions Of State And United States (CMS–2345–IFC3) – Interim Final with Comment
Date:
Topics:
- Financing & Reimbursement
- Prescription Drugs
Type: Regulations
Medicaid Prescription Spread Pricing
Date:
Topics:
- Financing & Reimbursement
- Affordable Care Act (ACA)
- Prescription Drugs
Type: Informational Bulletin
Final Rule and Interim Final Rule with Comment Period: Medicaid Program; Covered Outpatient Drug; Finalization of Line Extension Definition; and Change to the Rebate Calculation for Line Extension Drugs (CMS-2345-F2 and 2345-IFC2)
Date:
Topics:
- Affordable Care Act (ACA)
- Financing & Reimbursement
- Prescription Drugs
Type:
National Medicaid Drug Rebate Agreement (CMS-2397-FN)
Date:
Topics:
- Affordable Care Act (ACA)
- Financing & Reimbursement
- Prescription Drugs
Type: Regulations